Document Detail


Allergic contact dermatitis to topical preparations of bufexamac.
MedLine Citation:
PMID:  22881467     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
In Australia bufexamac is mainly used for pharmacist-initiated local treatment of various dermatoses. The European Medicines Agency's Committee for Medicinal Products for Human Use recently recommended that marketing authorisation for bufexamac-containing preparations be revoked throughout the European Union because of the risk of severe allergic contact dermatitis. We retrospectively reviewed the patch test database at the Skin and Cancer Foundation Inc. and identified 19 cases of positive reactions to bufexamac (5% petrolatum) from 451 people patch tested. The bufexamac reaction was deemed relevant to the presenting dermatitis in 13 of 19 (68%) patients. Bufexamac allergic contact dermatitis is under-reported in the English literature. We wish to emphasise the severity and the unusually polymorphic eruptions observed in some of the cases. Clinicians should consider the possibility of allergic contact dermatitis to bufexamac-containing preparations in all patients where there is a history of exposure, even if used for only a short time.
Authors:
Yan Pan; Rosemary Nixon
Related Documents :
22436057 - Asian consensus report on functional dyspepsia: necessary and ready?
19668027 - Same is different: a case report and literature review of staphylococcus aureus metasta...
14139997 - Bronchiolar emphysema. a report of a necropsied case of diffuse bronchiolectasis and re...
24373757 - Drug-induced lupus erythematosus presenting with cardiac tamponade: a case report and l...
15496237 - Crimean-congo hemorrhagic fever in turkey.
22795167 - A case of extramedullary plasmacytoma in the sphenoid sinus with unilateral loss of vis...
Publication Detail:
Type:  Journal Article     Date:  2012-03-02
Journal Detail:
Title:  The Australasian journal of dermatology     Volume:  53     ISSN:  1440-0960     ISO Abbreviation:  Australas. J. Dermatol.     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-08-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0135232     Medline TA:  Australas J Dermatol     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  207-10     Citation Subset:  IM    
Copyright Information:
© 2012 The Authors. Australasian Journal of Dermatology © 2012 The Australasian College of Dermatologists.
Affiliation:
Occupational Dermatology Research and Education Centre, Skin and Cancer Foundation Inc., Melbourne, Victoria, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Low-dose cyclosporin improves the health-related quality of life in Japanese psoriasis patients diss...
Next Document:  Angiolymphoid hyperplasia with eosinophilia and Kimura's disease coexisting in the same patient: Evi...